Cargando…
Dexamethasone to combat cytokine storm in COVID-19: Clinical trials and preliminary evidence
Autores principales: | Sharun, Khan, Tiwari, Ruchi, Dhama, Jaideep, Dhama, Kuldeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IJS Publishing Group Ltd. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472975/ https://www.ncbi.nlm.nih.gov/pubmed/32896649 http://dx.doi.org/10.1016/j.ijsu.2020.08.038 |
Ejemplares similares
-
SARS-CoV-2 in semen: Potential for sexual transmission in COVID-19
por: Sharun, Khan, et al.
Publicado: (2020) -
Protease inhibitor GC376 for COVID-19: Lessons learned from feline infectious peritonitis
por: Sharun, Khan, et al.
Publicado: (2020) -
Dexamethasone: A boon for critically ill COVID-19 patients?
por: Patel, Shailesh Kumar, et al.
Publicado: (2020) -
Oxford-AstraZeneca COVID-19 vaccine (AZD1222) is ideal for resource-constrained low- and middle-income countries
por: Sharun, Khan, et al.
Publicado: (2021) -
COVID-19 and sunlight: Impact on SARS-CoV-2 transmissibility, morbidity, and mortality
por: Sharun, Khan, et al.
Publicado: (2021)